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observed when compared to the presence of GPP without 
GT (P < 0.05). Biopsies revealed similarities among GT 
patients with different genotypes (AA, Aa and aa), with the 
neutrophils prominently infiltrating the epidermis. Western-
blot analysis showed that the expression ratio of IL-36Ra/
IL-36γ in lesioned tongues with individuals harboring 
different genotypes (AA, Aa and aa, n = 3, respectively) 
decreased significantly compared to controls (n = 3). We 
describe the mechanism of GT for the first time: some cases 
of GT are caused by IL36RN mutations, while those lack-
ing mutations are associated with an imbalance in expres-
sion between IL-36Ra and IL-36γ proteins in tongue tissue.
Abbreviation
GT  Geographic tongue
BMG  Benign migratory glossitis
GPP  Generalized pustular psoriasis
IL-36Ra  Interleukin-36 receptor antagonist
DITRA  Deficiency of interleukin thirty-six–receptor 
antagonist
ACH  Acrodermatitis continua of hallopeau
FT  Fissure tongue
Introduction
Geographic tongue (GT [MIM:137400]), also known as 
benign migratory glossitis (BMG), is a benign inflamma-
tory disorder of the tongue characterized by erythematous 
lesions of desquamated filiform papillae, which is usually 
delineated by raised, white, circinate lines (Assimakopou-
los et al. 2002). The prevalence of GT varies from 0.2 to 
14.29% (Furlanetto et al. 2006), but most surveys show 
a range between 1.0 and 2.5% (Assimakopoulos et al. 
2002) while the etiology of GT remains unknown. Several 
Abstract Geographic tongue (GT) is a benign inflam-
matory disorder of unknown etiology. Epidemiology and 
histopathology in previous studies found that generalized 
pustular psoriasis (GPP) is a factor associated with GT, but 
the molecular mechanism remains obscure. To investigate 
the mechanism of GT, with and without GPP, three cohorts 
were recruited to conduct genotyping of IL36RN, which is 
the causative gene of GPP. In a family spanning three gen-
erations and diagnosed with only GT (“GT alone”), GT 
was caused by the c.115+6T>C/p.Arg10ArgfsX1 mutation 
in the IL36RN gene. An autosomal dominant inheritance 
pattern with incomplete penetrance was observed. In the 
cohort consisting of sporadic cases of “GT alone” (n = 48), 
significant associations between GT and three IL36RN vari-
ants (c.115+6T>C/p.Arg10ArgfsX1, c.169G>A/p.Val57Ile 
and c.29G>A/p.Arg10Gln) were shown. In the GPP patient 
cohort (n = 56) and GPP family member cohort (n = 67), 
a significant association between the c.115+6T>C muta-
tion and the simultaneous presence of GPP and GT was 
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GT-associated conditions have been reported, such as gen-
eralized pustular psoriasis (GPP), heredity, allergies, hor-
monal disturbances, juvenile diabetes, stress and Down 
syndrome (Assimakopoulos et al. 2002; Redman et al. 
1972). Among them, GPP was commonly proposed to be 
an associated factor. This was based on the evidence of an 
increased prevalence of geographic tongue in GPP patients 
(Morris et al. 1992), similar histological findings in both 
the skin and tongue lesions (Femiano 2001), and the paral-
lel improvement of both entities after anti-psoriatic treat-
ment (Tholen and Lubach 1987). IL36RN was first identi-
fied as the causative gene for GPP patients in 2011 and the 
definition of DITRA (deficiency of interleukin 36-receptor 
antagonist) was proposed (Marrakchi et al. 2011; Onoufri-
adis et al. 2011). However, the molecular mechanism of GT 
has not been described.
In 2013, we reported mutations in IL36RN gene in 68 
Chinese patients with GPP (Li et al. 2013). At the follow-
up visits, a high prevalence of GT in both GPP patients and 
their non-GPP family members was observed. This inter-
esting phenomenon aroused our interests in studying the 
relationship between the IL36RN gene and expression of 
GT, in individuals both with, and without, GPP.
Results
Pedigree analysis for a Han Chinese family with only 
GT (“GT alone”)
In this study, a Han Chinese family manifesting with 
only GT, or “GT alone”, was recruited (Fig. 1). Here, 
“GT alone” refers to a GT phenotype lasting more than 
6 months without any known DITRA-associated diseases 
being noted. This family extended three generations and 
was comprised of 16 individuals, 6 of whom presented 
with GT and 1 who was shown to have fissure tongue (FT). 
Sanger sequencing of the IL36RN gene revealed that all 
Fig. 1  Pedigree of one “GT alone” family. Filled symbols denote the 
severe GT/FT presentations; cross-hatched symbols refer to the mild 
GT/FT presentations; open symbols denote absence of GT/FT. Geno-
types for c.115+6T>C allele were shown. Wt, wild-type. Family 1: 
One Chinese Han “GT alone” family without GPP, the proband was 
a 7-year-old female inpatient with Henoch-Schönlein purpura. GT, 
which was sustained and aggravated when she got an upper respira-
tory tract infection, was discovered by her father 3 months after birth. 
The family extends three generations, with seven members presenting 
GT or FT. Notably, none of the individuals in this family lacking an 
IL36RN null allele had GT or FT. The clinical manifestations were 
shown below
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seven clinically affected members were heterozygous for 
the c.115+6T>C(p.Arg10ArgfsX1) mutation. Three unaf-
fected individuals also carried this mutation. Notably, none 
of the individuals lacking IL36RN variants had GT or FT. 
In this family, GT was caused by the IL36RN mutation 
c.115+6T>C(p.Arg10ArgfsX1) present in a heterozygous 
state. The mutation was inherited in an autosomal dominant 
manner with an estimated penetrance of 70%.
Genotyping of sporadic individuals with “GT alone”
A total of 48 sporadic patients with “GT alone” (Sup-
plemental Table 1) and 168 randomly selected controls 
were recruited to be sequenced for the IL36RN gene 
(Table 1). Three variants, c.115+6T>C(p.Arg10ArgfsX1), 
c.169G>A(p.Val57Ile) and c.29G>A(p.Arg10Gln) were 
identified in 16 (33.3%) GT cases, with a combined allele 
frequency of 0.177. In the control group, the condition of 
the tongue was firstly determined through physical exami-
nation. None of the subjects presented with either the GT 
or FT lacked any DITRA-associated diseases (0/168). 
The combined allele frequency of the three variants in the 
control cohort was 0.015. A highly significant association 
between the combined IL36RN genotypes and GT was 
observed (odds ratio [OR] 16.30, 95% confidence inter-
vals [CIs] 5.57–47.68, P = 2.71E−9). The c.115+6T>C(p.
Arg10ArgfsX1) variant was most commonly observed in 
the “GT alone” cohort, and showed a statistically signifi-
cant association with GT when compared to the control 
subjects (OR 10.87, 95% CI 3.60–32.77, P = 2.69E−6). 
The c.169G>A(p.Val57Ile) variant was also significantly 
associated with GT (P = 0.01), whereas c.29G>A(p.Arg-
10Gln) was not (Table 1). 
We used four bioinformatics tools (see “Methods”) 
to analyze the impact of the three mutations on structure 
and eventual function of IL-36Ra. The results indicated 
the pathogenicity of the mutations c.115+6T>C and 
c.29G>A(p.Arg10Gln). However, the c.169G>A(p.Val-
57Ile) substitution had a weak effect on the structure and 
function of IL-36Ra (detailed in Table 2).
In three-dimensional conformation analysis, the angles 
changed in c.29G>A and c.169G>A amino acid substitu-
tions (Fig. 2c–h). Since these angles represented protein 
backbone, these changes might affect the three-dimensional 
structure. Moreover, c.115+6T>C mutation has proven to 
be a truncated protein by Farooq et al. (2013) and Sugi-
ura et al. (2013), three-dimensional conformation analysis 
for c.115+6T>C was conducted based on the premise of 
a truncated protein and showed the truncating was caused 
by a premature translation termination codon (TGA) at 
the 11th residue (Fig. 2b). Due to the lost of the functional 
domain, the function of IL-36Ra could be impaired.
Above all, the association between “GT alone” and these 
IL36RN variants suggests that they are genetic risk factors 
for “GT alone”.
Notably, a 21-year-old c.115+6T>C homozygous 
female was identified in the “GT alone” cohort. Although 
manifesting with a severe condition of GT with FT 
(Fig. 3b), this patient was never affected by GPP or any 
other DITRA-associated disease.
Genotype and phenotype analysis of GT for inpatients 
of GPP and family members of GPP probands
The tongue phenotypes and associated genotypes of the 
IL36RN gene was analyzed in 56 in-patients with GPP 
and 67 family members of the GPP probands (detailed 
in Supplemental Table 1). In total, 34/56 GPP patients 
(60.7%) were identified with IL36RN mutations. Among 
them, 31 were homozygous for c.115+6T>C, 1 was com-
pound heterozygous for c.115+6T>C and p.Glu112Lys, 
and 2 were heterozygous for c.115+6T>C. All 34 GPP 
patients with IL36RN mutations presented with GT. As for 
the severity of the GT lesions (the definitions of “severe” 
and “mild” were presented in diagnostic criteria in “Meth-
ods”), 31/34 homozygotes and one compound heterozygote 
(c.115+6T>C/Glu112Lys) were severely affected (Table 3; 
Fig. 4). The heterozygous GPP patient was accompa-
nied with a mild condition of GT (Supplemental Table 1). 
On the other hand, 22/56 GPP patients did not harbor 
Table 1  Frequency of the IL36RN variant alleles in the “GT alone” cohort
GT, geographic tongue; aa, homozygotes; Aa, heterozygotes; AA, wild-type
Genotype c.115+6T>C p.Val57Ile p.Arg10Gln Combined genotype
Control GT alone Control GT alone Control GT alone Control GT alone
AA 163 36 168 45 168 47 163 32
Aa 5 11 0 3 0 1 5 15
aa 0 1 0 0 0 0 0 1
Total 168 48 168 48 168 48 168 48
P = 2.69E−6 P = 0.01 P = 0.222 P = 2.17E−9
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any mutations in IL36RN. Of these 22 GPP patients, 13 
(59.09%) had GT (9 severe, 4 mild), and 9 (40.91%) had a 
tongue that appeared to be normal (Table 3). A significant 
association between the c.115+6T>C mutation and the 
presence of GPP with a GT phenotype was observed when 
compared to those presenting with GPP but lacking a diag-
nosis of GT (P = 2.17E−4). As for the family members 
of the GPP probands, 42 family members with IL36RN 
mutations were recruited. Notably, 7/42 were homozygous 
for c.115+6T>C, all of whom presented with “severe” 
GT (Fig. 4, F4-II-1, F3-II-1, F7-II-2; Fig. 5, Family2-II-2, 
II-3, II-4). This included one patient who also presented 
with acrodermatitis continua of hallopeau (ACH) (Fig. 4, 
F4-II-1). A total of 32/42 individuals were heterozygous 
for c.115+6T>C. Among the heterozygous cases, 23/32 
(71.9%) had “GT alone” (16 mild, 7 severe), and 9 (28.1%) 
were unaffected. GT was not found in three wild-type 
individuals. A total of 13 families encompassing 25 fam-
ily members were recruited from GPP probands lacking 
IL36RN mutations. Of these 25 individuals, only 2 (8.0%) 
had “GT alone”.
Dorsal lingual mucosa biopsy and western‑blot analysis 
for GT patients with different genotypes
To further investigate the histology manifestation and 
IL-36Ra-associated proteins expression in GT patients 
with IL36RN mutations, histological examination and west-
ern-blot analysis was conducted. Dorsal lingual mucosa 
specimens were obtained from 12 volunteers and included 
individuals who were: (1) homozygous for c.115+6T>C 
and manifested with both GT and GPP (n = 3), (2) het-
erozygous for c.115+6T>C and presented with “GT alone” 
(n = 3), (3) found to have a wild-type genotype, but were 
diagnosed with “GT alone” (n = 3), and healthy controls 
(n = 3). The oral histology examinations revealed the simi-
larities in the manifestation of GT relative to the different 
genotypes (Fig. 6a, b), and showed that the neutrophils 
prominently infiltrated the epidermis.
Western-blot analysis for the 12 specimens indicated 
that there is an imbalance in expression between IL-36Ra 
and IL-36γ in lingual mucosal tissue. This may lead to the 
GT phenotype despite individuals presenting with differ-
ent genotypes. Compared to healthy controls, the protein 
expression ratio between IL-36Ra and IL-36γ (IL-36Ra/
IL-36γ) in lesioned lingual mucosa from GT patients with 
different genotypes (AA, Aa and aa) were significantly 
decreased (n = 3; “aa” vs. “control”, P < 0.001; “Aa” 
vs. “control”, P < 0.001; “AA” vs. “control”, P < 0.01) 
(Fig. 6c–e). This suggests that the imbalance between IL-
36Ra and IL-36γ expression results in the GT phenotype. 
Briefly, the over-expression of IL-36γ combined with the 
insufficient expression of the protective protein IL-36Ra 
leads to the formation of GT. Furthermore, IL-36Ra/IL-36γ 
was significantly increased in Aa and AA genotypes in con-
trast to the aa genotypes (Fig. 6).
However, unlike its negative expression in the skin tissue 
of healthy controls, IL-36Ra was positively expressed in 
Table 2  The bioinformatics 
analysis for mutations of 
IL36RN
a The conservation scores of this site (9-conserved, 1-variable), calculated by ConSurf
b Predict possible impact of an amino acid substitution on the structure and function PolyPhen-2, the pre-
dict scores are listed in brackets
c Protein stability change upon mutation was computed by DUET, scores are listed in brackets, the unit is 
kcal/mol
d The association between the mutations and disease were predicted by MutationTaster
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healthy tongue tissues (Fig. 6f). In lingual mucosal tissue, 
the IL-36Ra protein was severely impaired in homozygous 
(aa) subjects, with lower expression levels in heterozy-
gous individuals (Aa) and higher expression in wild-type 
(AA) subjects manifesting with GT (Fig. 6c). There were 
no significant differences among “Aa”, “AA” and “control” 
groups. But when comparing “aa” genotypes to “Aa”, “AA” 
and “control” groups, these three groups indicated signifi-
cantly increased IL-36Ra (P < 0.05) protein expression 
(Fig. 6d). IL-36γ is expressed in both healthy controls and 
all GT subjects, regardless of which genotypes are found. 
Fig. 2  Three-dimensional con-
formation analysis and structure 
change of human IL36RN 
protein. a The 3D structure of 
monomer IL36RN (PDB id: 
4P0L). Red segment, blue seg-
ment and yellow segment repre-
sented the Arg10 residue, Val57 
residue and Glu112 residue, 
respectively. These sites located 
on different β-sheets. b The 
mutation, c.115+6T>C, could 
product a premature translation 
termination codon (TGA) at the 
11th residue. The gray segment 
was the potential truncated part. 
c, d The structure and angles 
of three residues in wild-type 
IL36RN (Phe9-Arg10-Met11) 
and mutant protein (Phe9-
Gln10-Met11). e, f The struc-
ture and angles of three residues 
in wild-type IL36RN (Pro56-
Val57-Ile58) and mutant protein 
(Pro56-Ile57-Ile58). g, h The 
structure and angles of three 
residues in wild-type IL36RN 
(Phe111-Glu112-Ser113) 
and mutant protein (Phe111-
Lys112-Ser113). Angles 
changed in 3 variants
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No significant differences were found in IL-36γ expression 
among individuals with GT and varying genotypes.
Discussion
Geographic tongue was first reported by Rayer in 1831 
(Assimakopoulos et al. 2002), and the etiology of GT still 
remains unclear. This study reveals the mechanism of GT 
for the first time. In the “GT alone” multiplex family, GT 
was caused by autosomal dominant IL36RN mutations with 
incomplete penetrance, but were also identified in GPP 
patients and their family members. GT is significantly asso-
ciated with IL36RN mutations in the sporadic “GT alone” 
cohort. For GT with IL36RN mutations, we propose that 
GT can be regarded as a localized manifestation of GPP or 
a new phenotype of DITRA. A semi-dominant inheritance 
pattern was observed when GPP was combined with GT as 
an entity. In contrast to this, and as shown by western-blot 
analysis, the presence of GT in wild-type individuals were 
associated with an imbalance in protein expression between 
IL-36Ra and IL-36γ in tongue tissue.
First of all, GT was confirmed to be caused by an 
IL36RN mutation through studying the “GT alone” family. 
Genotyping and pedigree analysis of this “GT alone” fam-
ily, which spans three generations, showed that the causative 
IL36RN mutation (c.115+6T>C/p.Arg10ArgfsX1) existed 
in a heterozygous state. GT is inherited in an autosomal 
Fig. 3  The clinical features in sporadic GT alone patients. a GT alone with “Aa” in sporadic cohort. b GT alone with “aa” in sporadic cohort. c 
Reexamining the tongue condition of a control with “aa” we recruited in 2013, it was found that he was affected by severe GT
Figs. 4 and 5  Six typical families affected with GPP and GT. Single 
asterisk denotes individuals with GPP; double asterisk denotes ACH; 
triple asterisk denotes fungiform papilla hyperplasia. Filled symbols 
denote the severe GT/FT presentations; cross-hatched symbols refer 
to the mild GT/FT presentations; open symbols denote absence of 
GT/FT; Genotypes for c.115+6T>C alleles are shown. Wt, wild-type. 
Family 2–7 were typical or remarkable pedigrees from the families 
with GPP that were recruited and a semi-dominant inheritance pattern 
was shown. Homozygotes had GPP or severe sustained “GT alone”, 
most heterozygotes had milder “GT alone” which was inclined to be 
self-healing, while some of the heterozygotes were unaffected. GT 
and FT could coexist in the same family. Remarkably, in family 2, the 
male homozygous proband (family 2; II-6) was affected with severe 
GPP and GT; however, the female homozygous siblings (family 2; 
II-2, 3, 4), who ranged from 7 to 23 years of age, were affected by 
severe “GT alone” and were never affected with GPP. In family 3, the 
withdrawal of glucocorticoid treatment after 6 months in an “aa” GPP 
patient revealed the GT phenotype (family 3-II-2). Family 4 showed 
that ACH (II-1), GPP(II-2), and GT/FT could coexist in the same 
family. Specifically in family 7, a sustained condition of fungiform 
papilla hyperplasia(II-2) was seen in a female homozygote without 
being affected by GPP
▸
Table 3  The prevalence of GT in GPPs and family members with c.115+6T>C variant
GPP, generalized pustular psoriasis; GT, geographic tongue
Genotype GPP Family members (GPP with mutations) Family members (GPP without muta-
tions)
With GT Without GT With GT Without GT With GT Without GT
AA 13 (59.1%) 9 0 (0%) 3 2 (8.0%) 23
Aa 2 (100%) 0 23 (69.7%) 9 – –
aa 32 (100%) 0 7 (100%) 0 – –
Total 47 (83.9%) 9 30 (70.5%) 12 2 (8.0%) 23
P = 2.17E−4 – –
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dominant inheritance pattern with an estimated penetrance 
of 70% in this family. Next, genotyping of 48 individuals 
with sporadic cases of “GT alone” showed a highly sig-
nificant association between the IL36RN c.115+6T>C/p.
Arg10ArgfsX1 mutant allele and “GT alone” (OR 10.87, 
95% CI 3.60–32.77, P = 2.69E−6). This further suggested 
that this IL36RN mutation was a genetic risk factor for man-
ifesting “GT alone”. The association between GPP and GT 
248 Hum Genet (2017) 136:241–252
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was identified on the basis of an increase in prevalence of 
GT in both GPP cohort (83.9%, 47/56) and family member 
cohort (47.8%, 32/67), when compared to the control cohort 
(0/168) or previous literature reports (ranged from 0.2 to 
14.29%) (Furlanetto et al. 2006).
Three mutations, namely, c.115+6T>C/p.Arg10A-
rgfsX1, c.169G>A/p.Val57Ile and c.29G>A/p.Arg10Gln 
were identified in “GT alone” patients. The c.115+6T>C 
mutation was first reported by Farooq et al. (2013) in two 
Japanese patients with GPP and was demonstrated to lead 
to the complete lack of exon 3. This results in a premature 
termination codon, which was supported by reverse tran-
scriptase PCR (RT-PCR) analysis using total RNA from the 
patients’ skin. Sugiura et al. (2013) also revealed the same 
result and suggested that p.Arg10ArgfsX1(c.115+6T>C) is 
one of the founder mutations for GPP in the Japanese pop-
ulation. Furthermore, p.Arg10ArgfsX1(c.115+6T>C) was 
reported in Chinese (Li et al. 2013, 2014), Korean (Song 
et al. 2014) and Malay (Setta-Kaffetzi et al. 2013) patients 
with GPP in homozygous/compound heterozygous, or 
249Hum Genet (2017) 136:241–252 
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heterozygous state. In current study, by three-dimensional 
conformation analysis, the mutation could lead to a trun-
cated protein and lose the functional domain. Predictive 
results by software also indicate c.115+6T>C is a disease-
causing mutation. Then, western-blot analysis showed the 
negative expression of IL-36Ra both in skin tissue and 
tongue tissue of GPP patients with homozygous mutation 
of c.115+6T>C which demonstrated the pathogenicity of 
the c.115+6T>C mutation in homozygous state. The com-
plete absence of the protein reduced the capacity of inhib-
iting the IL-36-mediated NF-kB signaling pathway (Tau-
ber et al. 2016). The variants of c.169G>A/p.Val57Ile and 
c.29G>A/p.Arg10Gln are detected in our GT alone cohort 
and have not been reported in GPP patients in literatures to 
our knowledge. Modeling and predictive programs showed 
the pathogenicity for c.29G>A and the benign characteris-
tic for c.169G>A.
However, about 66.7% (32/48) of the individuals 
belonging to the sporadic “GT alone” cohort were found to 
lack IL36RN mutations, suggesting that IL36RN mutations 
are not the only disease-causing variants in GT patients. 
Another disease locus or other factors may be associated 
with the occurrence of GT.
The inheritance pattern of GPP was autosomal recessive 
when the IL36RN gene was initially identified (Marrakchi 
et al. 2011). The discovery of GPP patients with single het-
erozygous mutations (Setta-Kaffetzi et al. 2013; Sugiura 
et al. 2013; Körber et al. 2013), unaffected individuals with 
homozygous mutations (Li et al. 2013), as well as the clini-
cal heterogeneity, ranging from mild localized pustular 
variants to severe systemic GPP (Tauber et al. 2016; Hus-
sain et al. 2015), in homozygous/compound heterozygous 
states lead to confusion of the inheritance mode of GPP 
(Capon 2013). Hypotheses of a modifying gene, a second 
gene locus, tri-allelic disease inheritance patterns, epigenetic 
events and environmental factors were proposed to explain 
these confusing phenomena (Farooq et al. 2013; Tauber et al. 
2016). Tauber et al. (2016) assessed the functional impact of 
different IL36RN mutations by using site-directed mutagene-
sis and expression in HEK293T cells, and differentiated null 
mutations from hypomorphic mutations. Null mutations with 
complete absence of IL-36Ra were associated with severe 
clinical phenotypes, while hypomorphic mutations with 
decreased or unchanged protein expression were identified 
in both localized and generalized variants, and was thought 
to account for the clinical heterogeneity. In this study, the 
correlation between the same mutation (c.115+6T>C/p.
Arg10ArgfsX1) with different state (Aa, aa, AA) and clinical 
phenotypes was analyzed. In the GPP families, homozygotes 
or compound heterozygotes had GPP or severe “GT alone”, 
most heterozygotes had milder “GT alone”, and some het-
erozygotes were unaffected (Figs. 4, 5). The inheritance 
pattern in our multiplex “GT alone” family was autosomal 
dominant (Fig. 1). Above all, we propose that GT is a local-
ized manifestation of GPP, and the inheritance pattern of 
GPP combined with GT is semi-dominant, in that homozy-
gotes or compound heterozygotes had a severe phenotype, 
whereas heterozygote either had a milder manifestation or 
no disease phenotype (Palmer et al. 2006). A semi-dominant 
genetic model explains the phenomenon of pathogenic het-
erozygotic and non-pathogenic homozygotic in GPP. This 
reminded us of “the two normal controls of c.115+6T>C 
variant in a homozygous state” we have previously reported 
(Li et al. 2013). We reexamined one of the homozygous nor-
mal control we managed to contact and found the condition 
of severe GT (Fig. 3c). The importance of tongue condition 
examination for GPP family members should be empha-
sized, while the GT/FT conditions were sometimes ignored 
in previous literatures about DITRA. Genetic counseling and 
genotyping should be carried out for GT-affected couples. 
However, the pathophysiological mechanism of homozygous 
alleles manifested in localized GT or severe systemic GPP 
(family 2), and the same heterozygous allele with variable 
clinical manifestations still remains unclear.
Secondly, we prove that the imbalance of IL-36Ra and 
IL-36γ is associated with GT of different genotypes (AA, 
Aa and aa) by western-blot analysis semi-quantitatively. 
IL-36Ra, encoded by the IL36RN gene, can block the 
downstream inflammatory signal pathway (NF-κB and 
MAP kinases) which is activated by IL-36 (IL-36α, IL-36β 
Fig. 6  Differences in clinical features, histopathologic characteristics 
and IL-36Ra/IL-36γ protein expression among GT cases with differ-
ent genotypes. a GT with different genotypes (patient No. 11, No. 82, 
No. 114 from left to right, and a healthy control on right, detailed in 
supplemental Table 1). b Biopsy of lesioned tongue tissue shows neu-
trophil infiltration in epidermis. c, d, f The expression of IL-36Ra and 
IL-36γ in lingual mucosal tissue of GT patients with different geno-
types, aa, homozygotes of c.115+6T>C mutations simultaneously 
affected with GT and GPP; Aa, c.115+6T>C heterozygotes with GT 
alone; AA, wild-type “GT alone” patients. The expression of IL-36Ra 
in lingual mucosal tissue was negative in the aa group, low in the Aa 
and high in AA groups. No significant differences in expression levels 
were found among the Aa, AA and control groups. Compared to the 
“aa” genotypes, those three groups were all significantly increased 
expressed (specimen 1 from patient No. 11; 2: No. 14; 3: No. 17; 4: 
No. 82; 5: No. 74; 6: No. 60; 7: No. 173; 8: No. 114; 9: No. 116). d 
IL-36γ is expressed in both healthy controls and all the GT patients 
with different genotypes. No significant differences were found 
among GTs of different genotypes. Compared with healthy controls, 
the protein expression ratio between IL-36Ra and IL-36γ (IL36-Ra/
IL-36γ) in lesioned lingual mucosa from GT patients with different 
genotypes (AA, Aa and aa) were significantly decreased (n = 3). 
Additionally, IL-36Ra/IL-36γ was significantly increased in Aa and 
AA genotypes in contrast to the aa genotype (*P < 0.05, **P < 0.01, 
***P < 0.001). e The expression of IL-36Ra and IL-36γ in lingual 
mucosal tissue of GT and skin tissue of GPP cases from individuals 
with different genotypes. Skin tissue from a GPP patient with an aa 
genotype and heathy, wild-type samples served as negative controls 
for IL-36Ra. Skin tissue from a GPP patient with an AA genotype 
served as the positive control for IL-36Ra and IL-36γ
◂
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and IL-36γ) through competitively binding to the IL-36 
receptor (IL-36R) (Dietrich and Gabay 2014). IL-36Ra, 
IL-36 and IL-36R are mainly expressed in epithelial tis-
sues including skin, trachea, and esophagus (Marrakchi 
et al. 2011). Various inflammatory and immunological dis-
eases, such as inflammatory bowel disease (Nishida et al. 
2016), systemic lupus erythematosus (Chu et al. 2015), 
and particularly psoriasis, were discovered to have elevated 
expression levels of IL-36 cytokines. IL-36γ was regarded 
as a valuable psoriasis-specific biomarker in both periph-
eral blood serum and the lesional skin tissue of psoriasis 
patients (D’Erme et al. 2015). The hypothesis of dysregu-
lation among IL-36 and IL-36Ra cytokines was proposed 
to explain the predisposition to common forms of psoriasis 
(Marrakchi et al. 2011). IL-36Ra is a very potent antago-
nist of the IL-36R-mediated response to IL-36γ at a ratio of 
IL-36Ra:IL-36γ<1 (Debets et al. 2001). This study proved 
that the expression ratio of IL-36Ra/IL-36γ in lingual 
mucosal tissue from GT patients with different genotypes 
were significantly decreased compared with healthy con-
trols. This indicates that the imbalance between IL-36Ra 
and IL-36γ expression results in the GT phenotype. Spe-
cifically, for the “aa” genotype, the absent expression of IL-
36Ra protein resulting from the mutant IL36RN causes the 
sustained phenotype of GT. This is because of the failure 
of this protein to act as an antagonist for the IL-36 signal-
ing pathway. For the “Aa” genotype, the expression of the 
IL-36Ra protein is insufficient, leading to the relative over-
expression of IL-36γ, and the consequent occurrence of the 
GT phenotype. As for “AA” patients, although no IL36RN 
variant is found, the expression of IL-36γ is so excessive 
that the protective protein IL-36Ra is not sufficient to 
repress the inflammatory activities induced by IL-36γ.
Notably, in normal tongue tissue, the IL-36Ra and 
IL-36γ proteins are expressed, unlike the absent expres-
sion of both proteins in normal skin tissue (Fig. 6f). The 
difference in expression between skin and tongue tissue 
may explain the phenomenon that the family members with 
the “Aa” genotypes in GPP families are inclined to only 
involve the lingual mucosa rather than skin tissue. Com-
pared to skin tissue, an abundance of the IL-36Ra protec-
tive protein is required in tongue tissues in order to antag-
onize the pre-existing IL-36γ protein expressed. Thus, an 
insufficient quantity of IL-36Ra is more likely to occur in 
the tongue of an “Aa” individual, because of the defect in a 
single IL36RN allele.
On the other hand, the manifestation of GT in the absence 
of mutations, was associated with the inflammatory reac-
tion of increased IL-36γ and a decreased ratio of IL-36Ra/
IL-36γ. This may also be induced by infections or immuno-
logical diseases. Scarlatina, varicella, alopecia areata, alo-
pecia universalis, atopic dermatitis, localized scleroderma 
and Henoch-Schönlein purpura are combined with GT in 12 
patients belonging to the sporadic “GT alone” cohort (Sup-
plemental Table 1).
In conclusion, our study reveals the mechanism of GT 
for the first time. Some cases of GT are caused by auto-
somal dominant IL36RN mutations with incomplete pene-
trance. For GT associated with IL36RN mutations, we pro-
pose that GT can be classified as a new subtype of DITRA, 
and that the inheritance pattern of GPP combined with GT 
is semi-dominant. The higher prevalence of GT in popula-
tion may facilitate the further investigations of GPP which 
was constrained by the rarity (Hussain et al. 2015). We 
emphasize that the condition of tongue should be examined 
in “Aa” individuals, and GT is an indication for IL36RN 
screening. For GTs without IL36RN mutations, we prelimi-
narily confirmed the association with the imbalance expres-
sion between IL-36Ra and IL-36γ in tongue tissue.
Methods
Subjects
One Han Chinese family with “GT alone” (referring to GT 
that lasted more than 6 months without any known DITRA-
associated diseases), 48 sporadic patients with “GT alone” 
and 168 randomly selected controls were recruited in the 
study. An additional 56 inpatients with GPP and 67 fam-
ily members from GPP probands volunteered to participate 
in the study. The study was approved by the Medical Eth-
ics Committees of Shanghai Jiaotong University School of 
Medicine, China. Written informed consent was obtained 
from all the participants.
Diagnostic criteria
The diagnosis of GT was simultaneously established by a 
dermatologist and a dentist. The investigations were per-
formed on the basis of the medical history and clinical 
examination under natural and artificial light, in accord-
ance with chronic, migratory and macroscopic lesions 
on the tongue epithelium (Assimakopoulos et al. 2002). 
The history of “chronic course” was defined as “sus-
tained or intermittent over 6 months” in this study. The 
lesions were classified into four patterns: (1) patchy areas 
of desquamated filiform papillae; (2) bordered by an ery-
thematous band of inflammation; and (3) delineated by 
raised, white, circinate lines. In addition, some patients 
manifested with fissure tongue (FT). Since the association 
between GT and FT has been noticed (Assimakopoulos 
et al. 2002), FT was classified as pattern 4. The pattern 
number was recorded for all patients (see Supplemental 
Table 1) and photographs were obtained. Fungal micros-
copy was performed in each of the GT patients to rule out 
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the presence of candidiasis. The severity was estimated 
according to the extent of the lesions. More specifically, 
those lesions exceeding one-third of the surface area of 
the dorsum were defined as “severe”, while those lesions 
covering less than one-third of the dorsum were recorded 
as “mild”.
IL36RN genotyping
Genomic DNA samples were extracted from peripheral 
blood samples using TIANamp Blood DNA kits (TIAN-
GEN Biotech, Beijing, China) and were amplified by 
regular polymerase chain reaction (PCR). Primers flank-
ing all exons, as well as intron–exon boundaries of the 
IL36RN gene, were designed. The sequencing of PCR 
products was conducted on an Applied Biosystems 3730 
DNA analyzer (ABI incorporation, Carlsbad, California, 
USA).
Dorsal lingual mucosa biopsy
Dorsal lingual mucosa specimens were obtained from 12 
volunteers. This included individuals who were homozy-
gous for the c.115+6T>C mutation and presented with both 
GT and GPP (n = 3), individuals who were heterozygous for 
the c.115+6T>C mutation and presented with “GT alone” 
(n = 3), those with wild-type genotypes manifesting with “GT 
alone” (n = 3), and healthy controls (n = 3), respectively. Vol-
unteers are marked with asterisks in Supplemental Table 1.
Western‑blot analysis
Western-blot analysis was performed on the dorsal lingual 
mucosa specimens from the 12 individuals with IL-36Ra, 
Rabbit PcAb, IL-36γ, Mouse mAb (Abcam, Cambridge, 
UK) and anti-GAPDH mouse mAbs. This was followed 
by HRP-conjugated goat anti-rabbit IgG, goat anti-mouse 
IgG (H + L) treatment (Beyotime Biological Technology, 
Jiangsu, China), and ECL detection (Thermo Fisher Scien-
tific, Inc., MA, USA).
Statistical analysis
Data were analyzed with the SPSS 18.0 software package 
(SPSS Inc., Chicago, Illinois, USA) and Prism 5 software 
(GraphPad Software, San Diego, CA).
Modeling and bioinformatics analysis
To evaluate the impact of mutations on human IL36RN pro-
tein, the ConSurf program was performed (Ashkenazy et al. 
2016) to calculate the conservation scores of these mutation 
sites. The possible impact of the mutation on the structure 
and function of IL36RN was predicted by an online server, 
PolyPhen-2 (Adzhubei et al. 2010). The free energy change 
(ΔΔG) between wild-type and mutation was quantitatively 
computed by DUET web server (Douglas 2014) to identify 
protein stability change. MutationTaster (Schwarz et al. 
2014) was used to predict the association between muta-
tions and disease. Three-dimensional structure of human 
IL36RN was obtained from RCSB Protein Data Bank (PDB 
Id: 4P0L), the PyMOL Molecular Graphics system (Ver-
sion 1.3, Schrodinger LCC) was operated to mutate the 
amino acid and display the protein structure.
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